May 9, 2013 | Letter

Exceprt: The award —at $100.6 million, one of the largest broadband grants under the ARRA — has been a source of controversy.

>>
May 9, 2013 | Letter

Excerpt: We continue to have questions about how CPPW funds have been spent by HHS. The Committee supports initiatives designed to improve health outcomes and reduce chronic diseases.

>>
May 8, 2013 | Letter

To read a copy of the letter sent to the following state agencies, click here.

>>
May 8, 2013 | Letter

To read the letter, click here.

>>
May 8, 2013 | Letter

Excerpt: FDA stated that the information USPlabs submitted was ‘insufficient to defend the use of DMAA as an ingredient in dietary supplements’ and advised consumers not to buy or use any products containing the stimulant.

>>
May 3, 2013 | Letter

Excerpt: We write in strong support of the Food and Drug Administration's (FDA) announcement to apply a "removed for safety or efficacy" determination to the crushabale form of OxyContin. This decision by FDA will help mitigate the harmful effects of the nation's prescription drug abuse crisis. inculding the suffering it causes in families across our country.

>>

Pages